KORU Medical Systems, Inc. KRMD

Company achieves 18% revenue growth and raises gross margin guidance despite international headwinds and FESGO withdrawal.

Moby summary of KORU Medical Systems, Inc.'s Q2 2026 earnings call

MAHWAH, N.J., August 05, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026.

MAHWAH, N.J., July 29, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026.

MAHWAH, N.J., July 15, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2026 financial results on Wednesday, August 5, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss t

The United States market has shown robust growth, climbing 3.2% in the last week and up 31% over the past year, with earnings expected to grow annually by 16%. In this context of strong market performance, identifying stocks with solid financial foundations is crucial for investors looking to capitalize on potential gains. While the term "penny stocks" might seem outdated, these often-overlooked smaller or newer companies can offer unique opportunities for growth when supported by strong...

Moby summary of KORU Medical Systems, Inc.'s Q1 2026 earnings call

KORU Medical Systems (NASDAQ:KRMD) reported a “record start to the year” in the first quarter of 2026, posting revenue of $11.8 million, up 22% from the prior-year period, as the company pointed to domestic share gains in subcutaneous immunoglobulin (SCIg), accelerating international growth tied to

We can readily understand why investors are attracted to unprofitable companies. For example, although...